Metropolis Healthcare Limited has announced the outcome of its Nomination and Remuneration Committee meeting held on November 3, 2026. The committee approved the grant of 24,060 Restrictive Stock Units (RSUs) and 3,58,920 Employees Stock Options (ESOPs). Additionally, 65,600 equity shares were allotted under the MHL-RSU Plan, 2020, at an exercise price of INR 2/- per share.
Stock Benefit Approvals
Metropolis Healthcare Limited’s Nomination and Remuneration Committee convened on Tuesday, November 3, 2026, to consider and approve several key employee incentive schemes. The committee approved the grant of 24,060 units under the Metropolis – Restrictive Stock Units Plan, 2025, and 3,58,920 options under the Metropolis – Employees Stock Options Plan, 2025.
Equity Share Allotment
Furthermore, the committee approved the allotment of 65,600 equity shares under the Metropolis – Restrictive Stock Unit Plan, 2020 (MHL-RSU Plan, 2020). These shares were allotted at an exercise price of INR 2/- per share, aggregating to a total of INR 1,31,200/-. The newly allotted equity shares will rank pari-passu in all respects with the existing equity shares of the Company.
Meeting Details
The meeting commenced at 09:50 a.m. IST and concluded at 11:10 a.m. IST on the same day. Detailed information regarding the grant of stock benefits and the allotment of equity shares is provided in Annexure I and Annexure II, respectively.
Source: BSE
